• / Free eNewsletters & Magazine
  • / My Account
Home>Insiders>Ben F. Johnson, III

Ben F. Johnson, III

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  5. Research
  1. Arnott and Asness: Can You Time Strategic Beta?

    Rob Arnott and Cliff Asness agree on many fronts, but they have different views on how carefully you should consider valuation when deciding to invest in a factor strategy. 

  2. Can Anything Stop Vanguard?

    Short of an unlikely breach of investor trust, Morningstar’s Ben Johnson thinks the fund giant will continue its momentum.

  3. Keep Your Focus on Fees

    Our semi-annual Active/Passive barometer shows that expenses are one of the only reliable predictors of success, writes Morningstar’s Ben Johnson .

  4. Wisdom or Madness?

    Carefully consider your strategic-beta selections.

  5. The Whole Market for Free?

    A race to lower expense ratios on broad-market ETFs, along with other factors, has pushed the estimated holding costs of many funds to nearly zero, writes Morningstar's Ben Johnson

  6. Fixed-Income Investors: Face the Facts

    Current circumstances are a difficult pill to swallow for many bond investors, but that is no reason to offload your ballast, writes Morningstar’s Ben Johnson .

  7. What You Need to Know About 'Strategic Beta'

    As these sometimes complex new funds continue to grow, investors need to be selective, writes Morningstar’s Ben Johnson .

  8. A New Multi-Factor ETF for Your Watchlist

    Credible factors cleverly combined make MSCI Factor Select ETF compelling, says Morningstar ETFInvestor editor Ben Johnson .

  9. Get the Best Out of Active and Index Funds

    In this 60-minute roundtable report, Morningstar's Russ Kinnel, Ben Johnson , John Rekenthaler, and Christine Benz dissect indexing's popularity, index versus active fund performance, and how investors can effectively blend the best of both in a portfolio.

  10. Strategic Beta: Investment Fad or Opportunity?

    Strategic beta funds have seen substantial inflows recently, but investors should approach them with a healthy skepticism and a keen eye on costs, says Morningstar's Ben Johnson .

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.